Decreases the relative expression levels of SREBP-2 and HMG-CoA reductase, TC contents in blood and liver, increases the expression level of CYP7A1 to improve lipid levels in blood and lipid metabolism disorders. This evidence concerns the gene CYP7A1 and Disorder of lipid metabolism.